Your browser doesn't support javascript.
loading
Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren's syndrome-like disease.
Akgul, Ali; Freguia, Christian Furlan; Maddaloni, Massimo; Hoffman, Carol; Voigt, Alexandria; Nguyen, Cuong Q; Fanger, Neil A; Fanger, Gary R; Pascual, David W.
Afiliação
  • Akgul A; Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL, USA.
  • Freguia CF; Rise Therapeutics, Rockville, MD, USA.
  • Maddaloni M; Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL, USA.
  • Hoffman C; Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL, USA.
  • Voigt A; Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL, USA.
  • Nguyen CQ; Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL, USA.
  • Fanger NA; Virtici, Seattle, WA, USA.
  • Fanger GR; Rise Therapeutics, Rockville, MD, USA.
  • Pascual DW; Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL, USA. pascuald@ufl.edu.
Sci Rep ; 13(1): 19489, 2023 11 09.
Article em En | MEDLINE | ID: mdl-37945636

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Lactococcus lactis Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Lactococcus lactis Idioma: En Ano de publicação: 2023 Tipo de documento: Article